Home/Filings/4/0001437749-14-021674
4//SEC Filing

NovaBay Pharmaceuticals, Inc. 4

Accession 0001437749-14-021674

$NBYCIK 0001389545operating

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 5:15 PM ET

Size

4.4 KB

Accession

0001437749-14-021674

Insider Transaction Report

Form 4
Period: 2014-12-02
Najafi Ramin
DirectorChief Executive OfficerOther
Transactions
  • Purchase

    Common Stock

    2014-12-02$0.71/sh+18,000$12,7803,130,000 total

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001389545

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:15 PM ET
Size
4.4 KB